Results 31 to 40 of about 2,525 (238)

Trade in substandard and falsified medicines [PDF]

open access: yes, 2022
According to WHO, 10.5% of medicines in low- and middle-income countries are substandard or falsified (SF), which has a multidimensional impact on public health as well as severe economic and socioeconomic consequences. Constrained access, weak technical
Nhomsai Hagen, Cathrin Hauk, Lutz Heide
openaire   +3 more sources

Identification of Substandard and Falsified Medicines: Influence of Different Tolerance Limits and Use of Authenticity Inquiries. [PDF]

open access: yesAm J Trop Med Hyg, 2021
Substandard and falsified medicines have severe public health and socioeconomic effects, especially in low- and middle-income countries. The WHO has emphasized the need for reliable estimates of the prevalence of such medicines to efficiently respond to ...
Hauk C, Hagen N, Heide L.
europepmc   +3 more sources

Modeling the Health and Economic Impact of Substandard and Falsified Medicines: A Review of Existing Models and Approaches. [PDF]

open access: yesAm J Trop Med Hyg, 2022
Substandard and falsified medicines are harmful to patients, causing prolonged illness, side effects, and preventable deaths. Moreover, they have an impact on the health system and society more broadly by leading to additional care, higher disease burden,
Ozawa S   +3 more
europepmc   +3 more sources

Falsified Medicines, a Crime without Punishment [PDF]

open access: yesInternational Journal of Medicine and Surgery, 2017
Falsified medicines are a global threat that does not stop growing. Its trafficking causes more deaths than malaria while being more profitable than drug smuggling.
Marc GENTILINI, Quentin DUTEIL
openaire   +3 more sources

Comprehensive Characterisation of the Ketoprofen-β-Cyclodextrin Inclusion Complex Using X-ray Techniques and NMR Spectroscopy

open access: yesMolecules, 2021
Racemic ketoprofen (KP) and β-cyclodextrin (β-CD) powder samples from co-precipitation (1), evaporation (2), and heating-under-reflux (3) were analysed using X-ray techniques and nuclear magnetic resonance (NMR) spectroscopy.
Katarzyna Betlejewska-Kielak   +4 more
doaj   +1 more source

Introduction of Good Practices of Drug Verification (DPWL) in hospital practice in Poland in order to protect against counterfeit drugs and improve patient safety [PDF]

open access: yesFarmacja Polska, 2020
The phenomenon of counterfeit medicines is common in healthcare systems around the world, making it a global problem. The number of recorded cases of falsified drugs available on the market is increasing every year.
Piotr Merks   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy